FEB 08, 2018 1:30 PM PST

Applications of Preclinical Translational Imaging Technologies for Improved Modeling and Decision Making

Speakers
  • Senior Principle Research Scientist, AbbVie
    Biography
      Paul is a Senior Principle Research Scientist based at AbbVie, Inc. His research focuses on molecular imaging and utilizes translational imaging modalities for pre-clinical development such as PET/SPECT/CT/MRI, ultra-high frequency ultrasound, confocal laser endomicroscopy, photoacoustic technologies, and OCT. Paul has earned degrees in electrical engineering (B.S), doctor of veterinary medicine (DVM), and in biomedical engineering (PhD). He is a certificate holder of Nanobiology from the University of Michigan Rackham Graduate School and a Diplomate of the American College of Laboratory Animal Medicine. He previously served as the Director of Vaccine Development at the Michigan Nanotechnology Institute for Medicine and Biological Sciences at the University of Michigan (Ann Arbor, MI), and the Associate Director of the In Vivo Translational Core for the University of Michigan Medical School.

    Abstract:

    Preclinical translational imaging, and specifically molecular imaging methods such as positron emission tomography (PET) or single photon emission computed tomography (SPECT) as well as magnetic resonance imaging (MRI) are extremely useful tools in the drug discovery and development process.  Continuous progress in modern imaging technologies holds a great potential to extend efficiencies to drug discovery and translation and to reduce clinical attrition.  Newer technologies such as photoacoustic tomography and confocal laser endomicroscopy lend the ability to identify critical and highly specific biomarker information for oncology, neurology, and immunology strategies.  These approaches can significantly enhance preclinical and translational research. The discussion will provide an overview of the strengths of different imaging technologies and will focus on scientific translational applications in oncology, neurology, immunology, and safety. 


    Show Resources
    You May Also Like
    SEP 05, 2019 4:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 4:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    NOV 18, 2019 7:00 AM PST
    C.E. CREDITS
    NOV 18, 2019 7:00 AM PST
    DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    MAR 31, 2020 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    MAR 31, 2020 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: March 31, 2020 TIME: 7:30am PT, 10:30am PT Please join us for this webinar, during which we will present and discuss the promotion of NK cell-driven tumor immunity. In addition, we wil...
    Loading Comments...
    Show Resources